HDR UK Gateway
HDR Gateway logo

Bookmarks

University College London Hospitals Prostate MRI Dataset

Population Size

7,976

People

Population Size statistic card

Years

2019 - 2024

Years statistic card

Associated BioSamples

None/not available

Associated BioSamples statistic card

Geographic coverage

United Kingdom

Geographic coverage statistic card

Lead time

Data only
Lead time statistic card

Summary

OMOP CDM extract from UCLH containing patient-level data from 2019-04-01 to 2024-03-31 for research purposes

Documentation

Prostate cancer is a very common disease, and the second commonest cause of death from cancer for men in the UK. Diagnosing prostate cancer has recently changed to a pathway that requires a MRI scan to help find suspicious lesions within the prostate that can then be sampled using a needle (a biopsy). This has much improved the diagnosis in the UK and internationally. About 200,000 men in the UK will currently have an MRI scan of their prostate every year. However, there is a real shortage of trained experts to provide reports for these studies. This results in delays to diagnosis across the country and also sometimes incorrect reporting which can miss important cancers or cause patients to have unnecessary biopsies (with potential for infection and bleeding as two main risks of biopsy). Given the large numbers of men being investigated there is also a large healthcare system cost to diagnosing prostate cancer and avoiding unnecessary procedures would significantly reduce costs.

Based on the wealth of prostate MRI expertise at UCL and UCLH and the number of studies that we have done in men since 2004, we will develop the models to support an AI based automated reporting system that can address the shortage of trained radiologists in the UK and world wide. We also plan to develop along the way AI tools that radiologists can use to improve workflow and avoid incorrect interpretation of MRI studies.

Initially we aim to use images that we hold in our electronic health record (approximately 5000 prostate MRI studies). This will be used to explore and develop initial automated reporting and tools. These will then need to be further refined and tested before any of them can be used at UCLH and at other sites. This initial request for data sharing will seed the developmental process.

Dataset type

Health and disease

Dataset population size

7976

Keywords

Observations

Observed Node

Disambiguating Description

Measured Value

Measured Property

Observation Date

Persons

7976

Count

31 Mar 2024

Provenance

Purpose of dataset collection

Research cohort

Source of data extraction

EPR

Biological sample availability

None/not available

Details

Publishing frequency

Continuous

Version

1.0.0

Modified

11/06/2026

Coverage

Start date

01/04/2019

End date

31/03/2024

Time lag

Not applicable

Geographic coverage

United Kingdom

Minimum age range

13

Maximum age range

95

Accessibility

Language

en

Alignment with standardised data models

OMOP

Controlled vocabulary

SNOMED CT, LOINC, OPCS4, RXNORM, RXNORM EXTENSION, ICD10

Format

application/parquet

Data Access Request

Dataset pipeline status

Not available

Access rights

In Progress

Access method category

TRE/SDE

Demographics

Dataset Types: Health and disease


Collection Sources: